JP2003522768A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003522768A5 JP2003522768A5 JP2001558442A JP2001558442A JP2003522768A5 JP 2003522768 A5 JP2003522768 A5 JP 2003522768A5 JP 2001558442 A JP2001558442 A JP 2001558442A JP 2001558442 A JP2001558442 A JP 2001558442A JP 2003522768 A5 JP2003522768 A5 JP 2003522768A5
- Authority
- JP
- Japan
- Prior art keywords
- signs
- administered
- makovec
- bronchoconstriction
- ovalbumin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 description 1
- 206010006482 Bronchospasm Diseases 0.000 description 1
- 229940126657 Compound 17 Drugs 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000007885 bronchoconstriction Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229940092253 ovalbumin Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2000A000127 | 2000-02-09 | ||
| ITTO2000A000127 | 2000-02-09 | ||
| IT2000TO000127A IT1320162B1 (it) | 2000-02-09 | 2000-02-09 | Derivati della tirosina ad attivita' anti leucotrienica, procedimentoper la loro preparazione e loro uso farmaceutico. |
| PCT/EP2001/001315 WO2001058892A1 (en) | 2000-02-09 | 2001-02-07 | Tyrosine derivatives with anti-leukotriene activity |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003522768A JP2003522768A (ja) | 2003-07-29 |
| JP2003522768A5 true JP2003522768A5 (enExample) | 2011-09-08 |
| JP4817577B2 JP4817577B2 (ja) | 2011-11-16 |
Family
ID=11457397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001558442A Expired - Fee Related JP4817577B2 (ja) | 2000-02-09 | 2001-02-07 | 抗ロイコトリエン活性を持つチロシン誘導体 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6605722B2 (enExample) |
| EP (1) | EP1255749B1 (enExample) |
| JP (1) | JP4817577B2 (enExample) |
| AT (1) | ATE354571T1 (enExample) |
| AU (1) | AU776214B2 (enExample) |
| CA (1) | CA2399451C (enExample) |
| DE (1) | DE60126745T2 (enExample) |
| ES (1) | ES2282234T3 (enExample) |
| IT (1) | IT1320162B1 (enExample) |
| PT (1) | PT1255749E (enExample) |
| WO (1) | WO2001058892A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001261654A (ja) * | 2000-03-21 | 2001-09-26 | Mitsui Chemicals Inc | キノリン誘導体およびそれを有効成分として含有する核内レセプター作動薬 |
| US7074810B2 (en) * | 2002-10-07 | 2006-07-11 | Bristol-Myers Squibb Company | Triazolone and triazolethione derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme |
| CN103145616B (zh) | 2003-06-06 | 2015-09-30 | 菲布罗根有限公司 | 含氮杂芳基化合物及其在增加内源性促红细胞生成素中的用途 |
| CN102351791B (zh) | 2006-01-27 | 2014-10-29 | 菲布罗根有限公司 | 使低氧诱导因子(hif)稳定的氰基异喹啉化合物 |
| AU2007234408B2 (en) | 2006-04-04 | 2011-05-19 | Fibrogen, Inc. | Pyrrolo- and thiazolo-pyridine compounds as HIF modulators |
| US7687705B2 (en) * | 2006-04-10 | 2010-03-30 | Alabama A&M University Institute | Efficient thermoelectric device |
| WO2010056767A1 (en) | 2008-11-14 | 2010-05-20 | Fibrogen, Inc. | Thiochromene derivatives as hip hydroxylase inhibitors |
| WO2013134660A1 (en) | 2012-03-09 | 2013-09-12 | Fibrogen, Inc. | 4 -hydroxy- isoquinoline compounds as hif hydroxylase inhibitors |
| SG11201500234YA (en) | 2012-07-16 | 2015-02-27 | Fibrogen Inc | Process for making isoquinoline compounds |
| EP3470397B1 (en) | 2012-07-16 | 2021-12-29 | Fibrogen, Inc. | Crystalline forms of a prolyl hydroxylase inhibitor |
| US8883823B2 (en) | 2012-07-16 | 2014-11-11 | Fibrogen, Inc. | Crystalline forms of a prolyl hydroxylase inhibitor |
| SG10202009266PA (en) | 2013-01-24 | 2020-10-29 | Fibrogen Inc | Crystalline forms of {[1-cyano-5-(4-chlorophenoxy)-4-hydroxy-isoquinoline-3-carbonyl]-amino}-acetic acid |
| CN109996541A (zh) | 2016-09-07 | 2019-07-09 | 普利安特治疗公司 | N-酰基氨基酸化合物及其使用方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1261835A (en) | 1984-08-20 | 1989-09-26 | Masaaki Toda | (fused) benz(thio)amides |
| GB8607294D0 (en) | 1985-04-17 | 1986-04-30 | Ici America Inc | Heterocyclic amide derivatives |
| FI94342C (fi) | 1988-03-29 | 1995-08-25 | Ciba Geigy Ag | Menetelmä uusien alkanofenonien valmistamiseksi |
| HU222344B1 (hu) | 1990-10-12 | 2003-06-28 | Merck Frosst Canada & Co. | Eljárás telítetlen hidroxi-alkil-kinolinsavak, és ezeket tartalmazó gyógyszerkészítmények előállítására |
| US5508408A (en) | 1993-09-10 | 1996-04-16 | Ciba-Geigy Corporation | Quinoline compound |
| ES2103180B1 (es) * | 1994-08-01 | 1998-04-01 | Menarini Lab | Fenilacetamidas con accion antagonista de los leucotrienos. |
| JPH11506425A (ja) | 1995-04-21 | 1999-06-08 | 第一製薬株式会社 | エチニルチアゾール誘導体 |
| DE19823722A1 (de) | 1998-05-27 | 1999-12-02 | Merckle Gmbh | Chinolinylmethoxyaryl-Verbindungen als duale Inhibitoren der Cyclooxygenase und 5-Lipoxygenase |
-
2000
- 2000-02-09 IT IT2000TO000127A patent/IT1320162B1/it active
-
2001
- 2001-02-07 CA CA002399451A patent/CA2399451C/en not_active Expired - Fee Related
- 2001-02-07 AU AU33742/01A patent/AU776214B2/en not_active Ceased
- 2001-02-07 JP JP2001558442A patent/JP4817577B2/ja not_active Expired - Fee Related
- 2001-02-07 WO PCT/EP2001/001315 patent/WO2001058892A1/en not_active Ceased
- 2001-02-07 PT PT01905744T patent/PT1255749E/pt unknown
- 2001-02-07 ES ES01905744T patent/ES2282234T3/es not_active Expired - Lifetime
- 2001-02-07 EP EP01905744A patent/EP1255749B1/en not_active Expired - Lifetime
- 2001-02-07 DE DE60126745T patent/DE60126745T2/de not_active Expired - Lifetime
- 2001-02-07 AT AT01905744T patent/ATE354571T1/de not_active IP Right Cessation
- 2001-02-07 US US10/203,424 patent/US6605722B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2039687A4 (en) | THERAPEUTIC OR PROPHYLACTIC AGENT AGAINST MULTIPLE SCLEROSIS | |
| WO2005069933A3 (en) | Methods of treating an inflammatory-related disease | |
| WO2001019776A3 (de) | Neuartige dicarbonsäurederivate mit pharmazeutischen eigenschaften | |
| IN2015DN01132A (enExample) | ||
| WO2005063745A3 (en) | Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof | |
| WO2004005286A3 (en) | Viral inhibitors | |
| WO2004018419A3 (en) | Benzimidazole quinolinones and uses thereof | |
| GB9914486D0 (en) | Medicaments | |
| WO2003005968A3 (en) | Dual release levodopa ethyl ester and decarboxylase inhibitor with immediate release levodopa | |
| CA2472954A1 (en) | Aza-arylpiperazines | |
| ZA200603538B (en) | P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same | |
| WO2002072584A3 (en) | Tetrahydro-pyrazino (1,2-a) indoles for the treatment of central nervous disorders | |
| MX344556B (es) | Agonista de subtipo de receptor 5-ht1a. | |
| RU2002100058A (ru) | Кристаллические производные 1-метилкарбапенема | |
| DK1228758T3 (da) | Anvendelse af sulfodehydroabietinsyre til behandling af inflammatorisk tarmsygdom | |
| WO2002102743A3 (de) | Deuterierte n- und alpha-substituierte diphenylalkoyxessigsäureaminoalkylester sowie diese verbindungen enthaltende arzneimittel | |
| RU2005129333A (ru) | 4-[(2,4-дихлор-5-метоксифенил)амино]-6-алкокси-3-хинолинкарбонитрилы для лечения ишемического повреждения | |
| WO2001030331A3 (en) | Therapeutic compositions including protein kinase c inhibitors | |
| EP1857442A3 (en) | Novel antimycobacterial compounds | |
| CA2438509A1 (en) | Use of cyclohexenone derivatives for the manufacture of a medicament in the treatment of dysuria | |
| CA2432177A1 (en) | Drug for prevention and/or therapy of endometriosis | |
| WO2004058303A3 (en) | Compositions of benzoquinolizine carboxylic acid antibiotic drugs | |
| WO2004048381A3 (en) | Pyrazoloazepine compounds as pharmaceutical agents | |
| EP2033637A4 (en) | THERAPEUTIC OR PROPHYLACTIC AGENT FOR LEUKEMIA | |
| CA2362211A1 (en) | Benzamide derivatives and medicament containing the same |